Led · Equity · Oct 2025

Founded in 2009 by Nicolas Priest and Sébastien Cobaud, Inelys provides accounting, audit and broader advisory services to roughly 4,000 SME and ETI clients. The group has expanded its portfolio to include legal, HR, CSR consulting, training, tax management and a furnished-rental management service that counts 12,000 clients. Inelys generates €25 million in annual revenue and employs 250 people. Growth to date has been driven by an active M&A strategy, with 22 accounting firms acquired since inception, including six so far in 2024. The company aims to double in size within five years. A central pillar of its plan is accelerating digital transformation around artificial intelligence to improve client service and operational efficiency. The fresh capital will also fund additional acquisitions in the Rhône-Alpes and Île-de-France regions.

Led · Seed · Sep 2025

Blue Charm builds patient engagement tools that recruit people with specific conditions and valid prescriptions to complete surveys during treatment, compensating participants and delivering medication-adherence insights to pharmaceutical partners. The company plans to enhance product development and expand services for pharma clients by developing advanced data analysis to better understand patient experiences and non-adherence. Blue Charm intends to grow its user base and corporate customer support capabilities and to build a team to attract and support those clients and participants. The company currently employs 14 full-time staff and seven contractors and expects to add 10 staff members by the end of 2026. Founded in 2020 and led by CEO Greg Patey, the business leverages the founder’s prior experience in life sciences and drug-sample distribution. The new funding is intended to support these product and team expansions.

Participated · Series A · May 2024

Netskrt Systems is a Content Delivery Network (CDN) provider focused on improving over-the-top (OTT) streaming video quality at the network edge. Its eCDN delivers tier 1 streaming video on demand (VOD) and live media across Canada, the United States, and the United Kingdom. The company’s solution targets high-quality viewing in urban, rural and remote areas as well as in-flight, and is particularly well suited to live sporting events and popular VOD content. With the Series A financing, Netskrt plans to expand its edge CDN footprint into international markets including Europe and South America, and into airlines and other travel markets. The investment will also fund expansion of customer support, engineering, and operations to fulfill its global eCDN mission. Netskrt secured CA$10 million in Series A equity financing, reflecting investor confidence in its team and technology.

Led · Series A · Apr 2023

Omy develops an AI-powered virtual skin consultant that analyzes user photos across multiple skin parameters to recommend personalized, vegan skincare ingredients and products. The company combines cosmetic chemistry with AI and sells products through select beauty salons in Québec and New Brunswick. Omy plans to expand its product line into North American markets and will acquire new production equipment to support that roll-out. The funding will also be used to grow the team: Omy currently has about 40 employees and plans to hire 23 more this year. To date the company has raised over CAD$13 million in total financing.

Led · Equity · Oct 2022

Blue-Zone Technologies is a Toronto-based clean‑tech pharmaceutical company that sustainably captures and recovers waste anesthetic gases and converts them into branded generic inhalation anesthetics. Founded in 1999 by Dusanka Filipovic and led by CEO Kipton Lade, the company runs a fully operational, GMP‑compliant, Health Canada‑licensed Drug Establishment Facility for anesthetic recovery, raw material and final product production. Blue-Zone collects unused anesthetics that would normally be vented into the environment and processes the collected material into its pure form, providing a sustainable and cost‑efficient source of inhalation anesthetic drugs. The company raised $8m in institutional financing in a round led by the Canadian venture capital arm of Crédit Mutuel Equity and Round Pound Ventures, LLC. Blue-Zone intends to use the proceeds to expand operations and broaden its business reach.